Visualitza per autor "Chan, Andrew"
Ara mostrant els elements 1-4 d 4
-
Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi method
Gold, Ralf; Barnett, Michael; Chan, Andrew; Feng, Huiyu; Fujihara, Kazuo; Giovannoni, Gavin; Montalban, Xavier; Tintore, Mar (SAGE Publications, 2023-07-14) -
Early Reduction of MRI Activity During 6 Months of Treatment With Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis
De Stefano, Nicola; Montalban Gairín, Xavier; Achiron, Anat; Derfuss, Tobias; Chan, Andrew; Barkhof, Frederik (Lippincott Williams & Wilkins, 2022-07) -
Multiple sclerosis: Immunopathological heterogeneity and its implications
Engelhardt, Britta; Comabella Lopez, Manuel; Chan, Andrew (Wiley, 2022-06) -
Specific Patterns of Immune Cell Dynamics May Explain the Early Onset and Prolonged Efficacy of Cladribine Tablets: A MAGNIFY-MS Substudy
Wiendl, Heinz; Schmierer, Klaus; Hodgkinson, Suzanne; Derfuss, Tobias; Sellebjerg, Finn; Montalban Gairín, Xavier; Chan, Andrew (Lippincott Williams & Wilkins, 2023-01)